In chronic myeloid leukaemia (CML), increased BCAT1 expression has been shown to elevate intracellular BCAA levels and activate the mTORC pathway) (Zhang & Han, 2017; Zheng et al., 2016). The gene discussed is BCAT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.